Valneva SE (VALN) Cash from Operations (2021 - 2026)

Valneva SE (VALN) posted quarterly Cash from Operations of 355041.73 for Q1 2026, up 95.97% year-on-year from 181174.33 in Q1 2025, and up 98.83% on a QoQ basis from 30243410.67 in Q4 2025.

Valneva SE (VALN) Cash from Operations (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Cash from Operations for 6 consecutive years, with 355041.73 the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Operations rose 95.97% year-over-year to 355041.73 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51742780.71 (up 2.53% YoY) and the FY2025 annual result came in at 60190953.22, up 21.31% from the prior year.
  • Cash from Operations rose to 355041.73 in Q1 2026 per VALN's latest filing, from 30243410.67 in the prior quarter.
  • Over the last five years, Cash from Operations for VALN reached as high as 73572248532.29 in Q3 2023 and fell as low as 73699730135.43 in Q2 2023.
  • A 5-year average of 38055265.92 and a median of 30243410.67 in 2025 frame the typical range for Cash from Operations.
  • The largest YoY upside for Cash from Operations was 72726.77% in 2023 against a maximum downside of 89158.54% in 2023.
  • Year by year, Cash from Operations stood at 64763253.48 in 2022, then decreased by 17.42% to 76042656.22 in 2023, then surged by 111.92% to 9067219.63 in 2024, then plunged by 433.55% to 30243410.67 in 2025, then surged by 98.83% to 355041.73 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 355041.73, 30243410.67, and 18148094.72 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -355,041.73

Historic Data

Download Data
DateValue
Mar 31, 2026 -355,041.73
Mar 31, 2026 -355,041.73
Dec 31, 2025 -30.24 Mn
Dec 31, 2025 -30.24 Mn
Sep 30, 2025 -18.15 Mn
Sep 30, 2025 -18.15 Mn
Jun 30, 2025 -3.00 Mn
Jun 30, 2025 -3.00 Mn
Mar 31, 2025 -8.80 Mn
Mar 31, 2025 -8.80 Mn
Dec 31, 2024 9.07 Mn
Dec 31, 2024 9.07 Mn
Sep 30, 2024 -11.42 Mn
Sep 30, 2024 -11.42 Mn
Jun 30, 2024 -41.93 Mn
Jun 30, 2024 -41.93 Mn
Mar 31, 2024 -32.21 Mn
Mar 31, 2024 -32.21 Mn
Dec 31, 2023 -76.04 Mn
Dec 31, 2023 -76.04 Mn